Clinical trial NL-OMON28305
Status: Recruiting (according to the registry)Phase not statedLatest change: Source: OMON (Netherlands) (via WHO ICTRP)
What's on this page?
This record’s status may be out of date
The trial was registered in March 13, 2015 and still shows as "recruiting" in the registry. Status information in other countries’ registries is often not updated; the trial may have ended or stopped. For current information, check the record itself.
Information in the record
Original title: Cannabidiol enhancement of exposure therapy in patients with phobias.
- Record number
- NL-OMON28305
- Registry
- OMON (Netherlands) (via WHO ICTRP)
- Status
- Recruiting (according to the registry)
- Type and phase
- Clinical trial, phase not stated
- Participants
- Target: 72
- Condition (as registered)
- Phobic anxiety disorders, fobische angststoornissen
- Countries
- Netherlands
- Topic in the guide
- Anxiety
Timeline
According to the OMON (Netherlands) (via WHO ICTRP) record. Future dates are the investigator’s estimates and may change.
- Registration: March 13, 2015
History
We check the record once a month via WHO ICTRP; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Anxiety: guide page · Thinking of taking part? Which specialist to see